X0306 4 2015-05-26 0 0000949699 PHARMACYCLICS INC PCYC 0001617239 Tomasello Shawn C/O PHARMACYCLICS, INC 995 EAST ARQUES AVENUE SUNNYVALE CA 94085 0 1 0 0 Chief Commercial Officer Common Stock 2015-05-26 4 D 0 50000 261.25 D 7302 D Common Stock 2015-05-26 4 U 0 7302 261.25 D 0 D Common Stock 2015-05-26 4 U 0 109 261.25 D 0 I IRA Common Stock 2015-05-26 4 U 0 61 261.25 D 0 I Spouse IRA Common Stock 2015-05-26 4 U 0 32 261.25 D 0 I Trust UTMA Stock Option (Right to Buy) 121.89 2015-05-26 4 D 0 100000 D 2024-08-18 Common Stock 100000 0 D Represents shares issuable pursuant to a Restricted Stock Unit Award that was cancelled in exchange for a cash payment, subject to applicable withholding taxes and pursuant to the procedures terms set forth in the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie. Includes 192 shares acquired under the Pharmacyclics, Inc. Employee Stock Purchase Plan on April 30, 2015. Price reflects aggregate per share consideration paid pursuant to the Tender Offer. This option was cancelled pursuant to the terms of the Merger Agreement in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement. /s/ Shawn Tomasello 2016-05-27